Introduction
The genus Trichocolea Dumortier (order Jungermanniales, family Trichocoleaceae) comprises 31 species of liverworts having a wide geographical distribution covering the southern Pacific Ocean (South Australia, Tasmania, and New Zealand). The main botanical features of plants belonging to the title genus have been extensively reviewed by Hatcher in 1958 [1] . The pool of secondary metabolites isolated from liverworts belonging to the title genus include benzoate esters, flavonoids, and labdane and isopimarane diterpenes. Although there are no reports on the folk and ethnomedical uses of plants belonging to the Trichocolea genus and few citations about pharmacological activities of individual principles or phytopreparations, data currently at disposition show a great potential to this concern [2] . The aim of this short review is to examine from phytochemical and pharmacological perspectives the different species belonging to the Trichocolea genus for which the extraction, isolation, structural characterization, and description of the biological activity of individual compounds and/or phytopreparations are reported in the literature. A substructure search, performed in the SciFinder Scholar database, and searches by keywords in PubMed, Medline, and Scopus, indicated that to date 5 species and a total of 21 secondary metabolites have been cited in the literature. For each plant, listed in alphabetic order a discussion on its phytochemistry and pharmacognosy is provided.
Trichocolea hatcheri E.A.Hodgs
Trichocolea hatcheri E.A.Hodgs is a species endemic of New Zealand featured by a small size, dark green color, and prostrate habit. Upon microscopic analysis, tapered leaf cilia, which lack swollen septae, and weak or absent cuticular ornamentation can be observed [3] . The first phytochemical study on this species appeared in the literature in 1998 when Perry and coworkers reported the isolation and structural characterization of prenyl benzoates 1-10 [4] . These Authors preliminarily observed that an extract of this species exerted a marked cytotoxic effect on monkey kidney (BSC) cells. Subsequent bioassay-guided fractionation by reverse phase chromatography led to the isolation of compounds 1-10. 
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All the isolates are characterized by the presence of 3'-OH groups in the aromatic ring instead of the "typical" 3'-OCH 3 of the other in so far investigated Trichocolea spp. Thus, the presence of such a moiety can be regarded as a distinguished feature of T. hatcheri inside the title genus. In the same year these Authors accomplished the synthesis of compound 1, along with two other phytochemicals, namely methyl 4-[(2E)-3,7-dimethyl-2,6-octadienyloxy]-3-methoxybenzoate 11, and methyl 4-[(2E)-3,7-dimethyl-2,6-octadienyloxy]-3-hydroxybenzoate 12 by alkylation of methyl vanillate with the suitably functionalized geranyl bromide [5] . Samples 1-3 were then assayed for their cytotoxic effects in the U.S. National Cancer Institute's AIDS-related lymphoma screens. Compound 1 showed an appreciable activity in the concentration range 9.7 x 10 -9 -2.5 x 10 -5 M. Compound 6 has been also screened for its cytotoxic, anti-microbial, and anti-oxidant effect, but showing only moderate activities in all tests [6] Schust.) is a species endemic of New Zealand and several isles of the southern Pacific Ocean. This liverwort is featured by a brilliant green color and the presence of overlapping leaves bearing numerous fine hairs (cilia). This liverwort lives on the forest floor and holds water with many hairs on its blades [7] . So far only one investigation has been carried out on this species and led to the isolation and structural characterization of the 3,3-dimethylallyloxy benzoate ester 13 [5] . Assayed as an in vitro anti-fungal agent, methyl 4-(3-methyl-2-butenoxy)-3-methoxybenzoate 13 was seen to exert only a weak activity against C. albicans and Tricophyton mentagrophytes.
Trichocolea mollissima (Hook. f. and Tayl.) Gott.
Trichocolea mollissima (Hook. f. and Tayl.) Gott., commonly known as "woollywort", is a liverwort commonly found in Australia (Tasmania, Victoria, South Wales, Queensland) and in northern New Zealand. It is featured by highly divided, densely arranged, and extremely small leaves, which lend it a woolly appearance. This liverwort typically grows in rainforest and beech forest, hanging from old tree trunks or growing erect on the forest floor [8] . The first investigation appeared in the literature in 1996 when Perry and coworkers disclosed the presence of geranyloxy benzoate derivatives 1-3 [5] . In subsequent biological assays compound 1 was seen to be highly cytotoxic in vitro against monkey kidney (BSC) cells at 15 µg/disk with 100% of growth inhibition and weakly active on C. albicans and T. mentagrophytes. In 1997 Lorimer and coworkers reported the isolation and structural characterization of the diterpene ent-1α-hydroxysandaracopimara-8(14),15-diene 14 from the ethanol extract of this liverwort. Compound 14 exhibited no appreciable pharmacological activity when assayed as an anti-microbial agent [9] . Seven years later Asakawa and coworkers recorded the presence in the same species of two additional ent-isopimarane-type diterpenoids (1R,2R)-ent-1,2-dihydroxyisopimara-8(14),15-diene 15 and (2R)-ent-2-hydroxyisopimara-8(14),15-diene 16 structurally related to 14 [10] .
Trichocolea pluma (Reinw. et. al.) Mont.
Trichocolea pluma (Reinw. et. al.) Mont. is a species endemic of New Zealand, Australia, and some other islands of the Pacific Ocean. It is very similar in structure to Trichocolea tomentella but have the ultimate cells of cilia of leaves are much more elongated [11] . As for other Trichocolea species mentioned above, also for this one, prenyl 3,4-dimethoxybenzoate esters represented the most abundant phytochemicals [12] . The biosynthetic precursor of such secondary metabolites, vanillic acid methyl ester 17, has been detected in the essential oil obtained by stem-distillation of T. pluma [13] . The remaining phytochemical investigations on this species reported in the literature refers to the isolation of a labdane diterpene, (-)-3α-hydroxylabda-8(17),12E,14-triene 18 [14] .
Trichocolea tomentella (Ehrhart) Dumortier
Trichocolea tomentella (Ehrhart) Dumortier, also known as "handsome woolywort" has a wide geographical distribution worldwide including north Europe, It is a large dioecious liverwort. It is conspicuous, with a characteristic greenish-white colour, highly dissected leaves and abundant paraphyllia and usually grows in moist, well-shaded places, particularly in deciduous forest, often near springs, streams or gullie [15] . T. tomentella is the most extensively liverwort of this genus studied from a phytochemical point of view. The first investigations on this species have been carried out between 1978 and 1981 and led to the isolation of three methoxybenzoate esters, trichocolein 18, tomentellin 19, and isotomentellin 20 [16] [17] .
Phytochemistry of the genus Trichocolea Natural Product Communications Vol. 13 (9) The investigations on the essential oil composition obtained from this species allowed to identify (-)-β-caryophyllene 21 among the main components [18] . One year later compounds 1-3 and 5 have been isolated from an ethanol extract of this species. Biological assays using 5 revealed that this latter to be effectively cytotoxic in vitro against monkey kidney (BSC) cells at 15 µg/disk with 100% of growth inhibition, but not on P-388 leukemia cells. It was also found that this same product was slightly active against C. albicans and T. mentagrophytes [4, 19] . Finally, T. tomentella has been selected as an experimental model to investigate the biosynthesis of the hemi-and monoterpenyl O-side chains of isoprenyl ethers featuring the genus Trichocolea by 13 C incorporation studies [20] .
Conclusions and future perspectives
In this short review we summarize the natural products isolated from liverworts belonging to the genus Trichocolea and analyse claims of pharmacological properties. In most cases a single compound is seen to be the effective pharmacological active agent. Nevertheless, further phytochemical studies need to be carried out in the near future to provide a more detailed pattern of the natural constituents and of the biologically active principles in extracts and/or phytopreparations from this genus. From data collected in this review, it is evident that the genus Trichocolea comprises therapeutically promising, interesting, and valuable species. Considering that only 5 out of 31 species of the title genus have been investigated so far and mostly only for the isolation and structural characterization of secondary metabolites, and that there are only few studies describing their pharmacological properties, this genus merits considerable attention in the on-going search for new bioactive principles and lead compounds.
